Gene · 9261
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs Expression in Response to rhNGF in Epithelial Corneal Cells: Focus on Neurotrophin Signaling Pathway. | Int J Mol Sci | 2022 | 35408969 | PubTator, text mining | PubMed |
| Skeletal muscle-specific overexpression of miR-486 limits mammary tumor-induced skeletal muscle functional limitations. | Mol Ther Nucleic Acids | 2022 | 35402076 | PubTator, text mining | PubMed |
| Hematopoietic Stem Cell Factors: Their Functional Role in Self-Renewal and Clinical Aspects. | Front Cell Dev Biol | 2022 | 35399522 | PubTator, text mining | PubMed |
| MAT2A facilitates PDCD6 methylation and promotes cell growth under glucose deprivation in cervical cancer. | Cell Death Discov | 2022 | 35396512 | PubTator, text mining | PubMed |
| Osthole-Mediated Inhibition of Neurotoxicity Induced by Ropivacaine via Amplification of the Cyclic Adenosine Monophosphate Signaling Pathway. | Dose Response | 2022 | 35392264 | PubTator, text mining | PubMed |
| The Candida albicans toxin candidalysin mediates distinct epithelial inflammatory responses through p38 and EGFR-ERK pathways. | Sci Signal | 2022 | 35380879 | PubTator, text mining | PubMed |
| Pre-defined gene co-expression modules in rheumatoid arthritis transition towards molecular health following anti-TNF therapy. | Rheumatology (Oxford) | 2022 | 35377444 | PubTator, text mining | PubMed |
| CXCL8 in Tumor Biology and Its Implications for Clinical Translation. | Front Mol Biosci | 2022 | 35372515 | PubTator, text mining | PubMed |
| Knockdown of Annexin A2 Enhances Radiosensitivity by Increasing G2/M-Phase Arrest, Apoptosis and Activating the p38 MAPK-HSP27 Pathway in Nasopharyngeal Carcinoma. | Front Oncol | 2022 | 35371986 | PubTator, text mining | PubMed |
| Noble Gases Therapy in Cardiocerebrovascular Diseases: The Novel Stars? | Front Cardiovasc Med | 2022 | 35369316 | PubTator, text mining | PubMed |
| Kinase domain autophosphorylation rewires the activity and substrate specificity of CK1 enzymes. | Mol Cell | 2022 | 35353987 | PubTator, text mining | PubMed |
| Electron Transport Lipids Fold Within Membrane-Like Interfaces. | Front Chem | 2022 | 35350775 | PubTator, text mining | PubMed |
| Using a System Pharmacology Method to Search for the Potential Targets and Pathways of Yinqiaosan against COVID-19. | J Healthc Eng | 2022 | 35340244 | PubTator, text mining | PubMed |
| MicroRNA-mRNA Regulatory Network Mediates Activation of mTOR and VEGF Signaling in African American Prostate Cancer. | Int J Mol Sci | 2022 | 35328346 | PubTator, text mining | PubMed |
| Is Autophagy Always a Barrier to Cisplatin Therapy? | Biomolecules | 2022 | 35327655 | PubTator, text mining | PubMed |
| Osmotic Stress Interferes with DNA Damage Response and H2AX Phosphorylation in Human Keratinocytes. | Cells | 2022 | 35326410 | PubTator, text mining | PubMed |
| MiR-103a-3p Promotes Zika Virus Replication by Targeting OTU Deubiquitinase 4 to Activate p38 Mitogen-Activated Protein Kinase Signaling Pathway. | Front Microbiol | 2022 | 35317262 | PubTator, text mining | PubMed |
| Heat shock protein 60 couples an oxidative stress-responsive p38/MK2 signaling and NF-κB survival machinery in cancer cells. | Redox Biol | 2022 | 35316673 | PubTator, text mining | PubMed |
| Targeting the COP9 signalosome for cancer therapy. | Cancer Biol Med | 2022 | 35315259 | PubTator, text mining | PubMed |
| A Systematic Review of Tissue and Single Cell Transcriptome/Proteome Studies of the Brain in Multiple Sclerosis. | Front Immunol | 2022 | 35309325 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/papers?page=31